Stability studies of hot-melt extruded ternary solid dispersions of poorly-water soluble indomethacin with poly(vinyl pyrrolidone-co-vinyl acetate) and polyethylene oxide

[1]  Noel M. Gately,et al.  Investigation of miscibility estimation methods between indomethacin and poly(vinylpyrrolidone‐co‐vinyl acetate) , 2018, International journal of pharmaceutics.

[2]  V. Zeleňák,et al.  Ordered cubic nanoporous silica support MCM-48 for delivery of poorly soluble drug indomethacin , 2018, Applied Surface Science.

[3]  R. Williams,et al.  Enhanced Dissolution of a Porous Carrier-Containing Ternary Amorphous Solid Dispersion System Prepared by a Hot Melt Method. , 2018, Journal of pharmaceutical sciences.

[4]  R. Suryanarayanan,et al.  Use of a Plasticizer for Physical Stability Prediction of Amorphous Solid Dispersions , 2017 .

[5]  J. Siepmann,et al.  PEO hot melt extrudates for controlled drug delivery: Importance of the molecular weight , 2016 .

[6]  G. Van den Mooter,et al.  The role of the carrier in the formulation of pharmaceutical solid dispersions. Part II: amorphous carriers , 2016, Expert opinion on drug delivery.

[7]  G. Mooter,et al.  The role of the carrier in the formulation of pharmaceutical solid dispersions. Part II: amorphous carriers , 2016 .

[8]  M. Hussain,et al.  Initial Drug Dissolution from Amorphous Solid Dispersions Controlled by Polymer Dissolution and Drug-Polymer Interaction , 2016, Pharmaceutical Research.

[9]  Bruno Sarmento,et al.  Amorphous solid dispersions: Rational selection of a manufacturing process. , 2016, Advanced drug delivery reviews.

[10]  F. Štěpánek,et al.  Non-invasive insight into the release mechanisms of a poorly soluble drug from amorphous solid dispersions by confocal Raman microscopy. , 2016, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[11]  J. Aylott,et al.  Indomethacin-Kollidon VA64 Extrudates: A Mechanistic Study of pH-Dependent Controlled Release. , 2016, Molecular pharmaceutics.

[12]  M. Hussain,et al.  Dissolution of Danazol Amorphous Solid Dispersions: Supersaturation and Phase Behavior as a Function of Drug Loading and Polymer Type. , 2016, Molecular pharmaceutics.

[13]  R. Williams,et al.  Challenges and Strategies in Thermal Processing of Amorphous Solid Dispersions: A Review , 2016, AAPS PharmSciTech.

[14]  C. Strachan,et al.  Amorphous solid dispersions of piroxicam and Soluplus(®): Qualitative and quantitative analysis of piroxicam recrystallization during storage. , 2015, International journal of pharmaceutics.

[15]  L. S. Taylor,et al.  Phase separation kinetics in amorphous solid dispersions upon exposure to water. , 2015, Molecular pharmaceutics.

[16]  S. Kazarian,et al.  Stability of indomethacin with relevance to the release from amorphous solid dispersions studied with ATR-FTIR spectroscopic imaging. , 2014, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[17]  Li Deng,et al.  Applications of poly(ethylene oxide) in controlled release tablet systems: a review , 2014, Drug development and industrial pharmacy.

[18]  Wei-guo Dai,et al.  Fundamental aspects of solid dispersion technology for poorly soluble drugs , 2013, Acta pharmaceutica Sinica. B.

[19]  T. Barder,et al.  Correlation of Inhibitory Effects of Polymers on Indomethacin Precipitation in Solution and Amorphous Solid Crystallization Based on Molecular Interaction , 2013, Pharmaceutical Research.

[20]  Q. Ping,et al.  Use of polymer combinations in the preparation of solid dispersions of a thermally unstable drug by hot-melt extrusion , 2013 .

[21]  G. Mooter,et al.  The use of amorphous solid dispersions: A formulation strategy to overcome poor solubility and dissolution rate. , 2012, Drug discovery today. Technologies.

[22]  Li Di,et al.  pH-Dependent solubility and permeability criteria for provisional biopharmaceutics classification (BCS and BDDCS) in early drug discovery. , 2012, Molecular pharmaceutics.

[23]  Feng Qian,et al.  Is a distinctive single Tg a reliable indicator for the homogeneity of amorphous solid dispersion? , 2010, International journal of pharmaceutics.

[24]  R. Bodmeier,et al.  Characterization and stability of solid dispersions based on PEG/polymer blends. , 2010, International journal of pharmaceutics.

[25]  Peng Wang,et al.  Effects of extrusion process parameters on the dissolution behavior of indomethacin in Eudragit E PO solid dispersions. , 2010, International journal of pharmaceutics.

[26]  G. Van den Mooter,et al.  Review: physical chemistry of solid dispersions , 2009 .

[27]  A. Van Schepdael,et al.  Characterization of ternary solid dispersions of Itraconazole in polyethylene glycol 6000/polyvidone-vinylacetate 64 blends. , 2008, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[28]  R. Chokshi,et al.  Stabilization of low glass transition temperature indomethacin formulations: impact of polymer-type and its concentration. , 2008, Journal of pharmaceutical sciences.

[29]  A. Van Schepdael,et al.  Formulation and characterization of ternary solid dispersions made up of Itraconazole and two excipients, TPGS 1000 and PVPVA 64, that were selected based on a supersaturation screening study. , 2008, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[30]  R. Zelkó,et al.  Tracking the physical aging of poly(ethylene oxide): A technical note , 2006, AAPS PharmSciTech.

[31]  John G. Lyons,et al.  Preparation of monolithic matrices for oral drug delivery using a supercritical fluid assisted hot melt extrusion process. , 2007, International journal of pharmaceutics.

[32]  G. Van den Mooter,et al.  Solid state characteristics of ternary solid dispersions composed of PVP VA64, Myrj 52 and itraconazole. , 2005, International journal of pharmaceutics.

[33]  Geert Verreck,et al.  Physical stability of the amorphous state of loperamide and two fragment molecules in solid dispersions with the polymers PVP-K30 and PVP-VA64. , 2005, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[34]  Bruno C. Hancock,et al.  What is the True Solubility Advantage for Amorphous Pharmaceuticals? , 2000, Pharmaceutical Research.

[35]  Charles E. Martin,et al.  Pharmaceutical Extrusion Technology , 2003 .

[36]  C Vervaet,et al.  Characterization of ibuprofen as a nontraditional plasticizer of ethyl cellulose. , 2002, Journal of pharmaceutical sciences.

[37]  D. Craig,et al.  The mechanisms of drug release from solid dispersions in water-soluble polymers. , 2002, International journal of pharmaceutics.

[38]  G Zografi,et al.  Fourier transform Raman spectroscopic study of the interaction of water vapor with amorphous polymers. , 2001, Journal of pharmaceutical sciences.

[39]  A. Serajuddin,et al.  Solid dispersion of poorly water-soluble drugs: early promises, subsequent problems, and recent breakthroughs. , 1999, Journal of pharmaceutical sciences.

[40]  Bruno C. Hancock,et al.  CHARACTERIZATION OF THE TIME SCALES OF MOLECULAR MOTION IN PHARMACEUTICALLY IMPORTANT GLASSES , 1999 .

[41]  Nikolaos A. Peppas,et al.  Crystal dissolution-controlled release systems: I. Physical characteristics and modeling analysis , 1997 .

[42]  S. Bekiranov,et al.  SOLUTION BEHAVIOR OF POLYETHYLENE OXIDE IN WATER AS A FUNCTION OF TEMPERATURE AND PRESSURE , 1997 .

[43]  A Apicella,et al.  Poly(ethylene oxide) (PEO) and different molecular weight PEO blends monolithic devices for drug release. , 1993, Biomaterials.

[44]  L. Struik The mechanical and physical ageing of semicrystalline polymers: 1 , 1987 .

[45]  L. Struik Mechanical behaviour and physical ageing of semi-crystalline polymers: 4 , 1987 .

[46]  L. Rockland,et al.  Saturated Salt Solutions for Static Control of Relative Humidity between 5° and 40° C. , 1960 .